4.8 Editorial Material

Membrane Cholesterol Regulates Macrophage Plasticity in Cancer

Journal

CELL METABOLISM
Volume 29, Issue 6, Pages 1238-1240

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2019.05.011

Keywords

-

Funding

  1. Italian Association for Cancer Research (AIRC) [IG 19885, IG 20085]
  2. Italian Association for Cancer Research (AIRC 5x100 project) [22757]
  3. Fondazione Cariplo, Italy
  4. Italian Ministry of Education, Universities and Research, Italy (MIUR) [2015YYKPNN_004, 2017BA9LM5]

Ask authors/readers for more resources

The pro-tumoral diversion of macrophages remains an unresolved paradox of tumor immunology and a conceptual gap in the understanding of tumor biology. Goossens et al. (2019) identify a new level of crossregulation by which tumors increase the membrane cholesterol efflux of macrophages to enhance their pro-tumoral activation in response to IL-4.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Immunology

Implications of metabolism-driven myeloid dysfunctions in cancer therapy

Laura Strauss, Valentina Guarneri, Alessandra Gennari, Antonio Sica

Summary: Immune homeostasis is disrupted in chronic inflammatory states like cancer, leading to excessive expansion of myeloid progenitors and aberrant immune responses. Metabolic dysfunctions play a critical role in influencing the balance between therapeutic efficacy and immune-related adverse effects, particularly in current immune checkpoint inhibitor therapy. Restoring immunometabolism may enhance host antitumor immunity and improve clinical outcomes.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection

Elettra Barberis, Virginia V. Vanella, Marco Falasca, Valeria Caneapero, Giuseppe Cappellano, Davide Raineri, Marco Ghirimoldi, Veronica De Giorgis, Chiara Puricelli, Rosanna Vaschetto, Pier Paolo Sainaghi, Stefania Bruno, Antonio Sica, Umberto Dianzani, Roberta Rolla, Annalisa Chiocchetti, Vincenzo Cantaluppi, Gianluca Baldanzi, Emilio Marengo, Marcello Manfredi

Summary: Limited knowledge of the host response to SARS-CoV-2 hinders understanding of COVID-19 pathogenesis and therapeutic strategies. This study revealed that SARS-CoV-2 infection modulates exosome content and their involvement in disease progression, highlighting the potential of plasma exosomes as biomarkers for disease severity. Proteomic analysis of patient-derived exosomes identified molecules implicated in immune response, inflammation, coagulation, and complement pathways associated with COVID-19 tissue damage and organ dysfunction. Moreover, the presence of SARS-CoV-2 RNA in exosomes suggests a potential route for viral spread.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Immunology

Heme catabolism by tumor-associated macrophages controls metastasis formation

Francesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, Mariangela Storto, Paolo Kunderfranco, Alberto Termanini, Fabio Pasqualini, Chiara Ali, Chiara Pandolfo, Francesco Sgambelluri, Giulia Grazia, Mario Santinami, Andrea Maurichi, Massimo Milione, Marco Erreni, Andrea Doni, Marco Fabbri, Laura Gribaldo, Eliana Rulli, Miguel Parreira Soares, Valter Torri, Roberta Mortarini, Andrea Anichini, Antonio Sica

Summary: This study identifies a distinct subset of TAMs with high rates of heme catabolism by HO-1, playing a critical role in shaping a prometastatic tumor microenvironment and favoring immunosuppression, angiogenesis and epithelial-to-mesenchymal transition. These TAMs originate from BM precursors, accumulate in the blood of tumor bearers, and preferentially localize at the invasive margin through Nrf2 activation and NF-kappa B1-CSF1R-C3aR axis coordination. Hindering their recruitment or deletion of HO-1 inhibits metastasis formation and enhances anticancer immunotherapy, making them a potential antimetastatic target and prognostic blood marker.

NATURE IMMUNOLOGY (2021)

Letter Oncology

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy

Matteo Bellone, Marco Bregni, Vincenzo Bronte, Stefano Ugel, Pier Francesco Ferrucci, Massimo Di Nicola, Paola Nistico, Gaia Zuccolotto, Antonio Rosato, Vincenzo Russo, Antonio Sica, Mario P. Colombo

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Letter Oncology

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020

Matteo Bellone, Arianna Brevi, Vincenzo Bronte, Silvia Dusi, Pier Francesco Ferrucci, Paola Nistico, Antonio Rosato, Vincenzo Russo, Antonio Sica, Gabriele Toietta, Mario Paolo Colombo

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Allergy

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases

Augusto Bleve, Francesca Motta, Barbara Durante, Chiara Pandolfo, Carlo Selmi, Antonio Sica

Summary: The immune system plays a crucial role in maintaining tissue homeostasis and defending against pathogens and cancer cells. However, the aging process leads to a decline in immune function, resulting in compromised immune responses and unresolved inflammation. This contributes to a subclinical syndrome of homeostatic frailty in the elderly, making them more susceptible to immune debilitation and chronic low-grade inflammation, which in turn increase the risk of chronic and degenerative diseases. This review focuses on the age-dependent changes in myeloid populations and their impact on frailty and diseases in the elderly.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Review Oncology

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective

Augusto Bleve, Francesca Maria Consonni, Chiara Porta, Valentina Garlatti, Antonio Sica

Summary: Immunotherapy has made significant progress in the treatment of cancer, but the presence of myeloid cells in the tumor microenvironment can greatly impact treatment response. Current strategies targeting TAMs and MDSCs are showing promising results in pre-clinical and clinical studies. Variability in immune profile within the tumor microenvironment, largely influenced by the frequency and phenotypic heterogeneity of infiltrating myeloid cells, can contribute to the variability in treatment response.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis

Maria Angela Masini, Valentina Bonetto, Marcello Manfredi, Anna Pasto, Elettra Barberis, Sara Timo, Virginia Vita Vanella, Elisa Robotti, Francesca Masetto, Francesca Andreoli, Alessandra Fiore, Sara Tavella, Antonio Sica, Massimo Donadelli, Emilio Marengo

Summary: The absence of gravity has significant impact on cancer cells, affecting their morphology, metabolism, and phenotype. Simulated microgravity can activate cellular motility pathways and enhance the migratory capability of tumor cells. Additionally, the absence of gravity can alter metabolic pathways, promoting the survival and proliferation of cancer cells.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Review Biochemistry & Molecular Biology

Precision Medicine Approaches with Metabolomics and Artificial Intelligence

Elettra Barberis, Shahzaib Khoso, Antonio Sica, Marco Falasca, Alessandra Gennari, Francesco Dondero, Antreas Afantitis, Marcello Manfredi

Summary: This review discusses the application of recent technological innovations in mass spectrometry to metabolomics analysis, with a focus on the use of artificial intelligence (AI) strategies. The article also explores the challenges and limitations of implementing metabolomics-AI systems, as well as recent tools and studies in disease classification and biomarker identification.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

Immunometabolic interference between cancer and COVID-19

Francesca Maria Consonni, Barbara Durante, Marcello Manfredi, Augusto Bleve, Chiara Pandolfo, Valentina Garlatti, Virginia Vita Vanella, Emilio Marengo, Elettra Barberis, Barbara Bottazzi, Sara Bombace, Ilaria My, Gianluigi Condorelli, Valter Torri, Antonio Sica

Summary: Despite being more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the mechanisms underlying the predisposition of cancer patients to severe forms of coronavirus disease 2019 (COVID-19) remain unknown. Utilizing a combination of flow cytometry and multiomics, this study identifies immunometabolic pathways that intersect with cancer and SARS-CoV-2 infection. The findings suggest that cancer not only dampens the inflammatory state in COVID-19 patients but also weakens their metabolic state through interference with NAD(+)-dependent immune homeostasis.

FRONTIERS IN IMMUNOLOGY (2023)

Editorial Material Immunology

Specialization determines outcomes in inflammation and cancer

Antonio Sica, Massimo Lazzeri

Summary: Tissue-resident macrophages promote protective fibrosis in pancreatitis for pancreatic homeostasis maintenance, while in pancreatic ductal adenocarcinoma, they facilitate tumor progression through stromal desmoplasia.

NATURE IMMUNOLOGY (2023)

Article Allergy

Inflammaging and Osteoarthritis

Francesca Motta, Elisa Barone, Antonio Sica, Carlo Selmi

Summary: Osteoarthritis is a prevalent disease in the elderly population, and the role of inflammaging in its development has been explored. Inflammaging affects immune response and cartilage degradation, and may serve as a potential therapeutic target.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

No Data Available